Ling Geoffrey M.D. 4
4 · Celularity Inc · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Celularity IncCELU
Ling Geoffrey M.D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-19+84,746→ 1,334,746 totalExercise: $2.23Exp: 2034-12-19→ Class A Common Stock (84,746 underlying) - Award
Class A Common Stock
2024-12-19+67,416→ 67,416 total
Footnotes (3)
- [F1]These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- [F2]Includes 67,416 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
- [F3]This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, December 19, 2024, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.